September 2022 – November 2023 (15 months)



Alleanza Contro Il Cancro, Italy

Biomedicinske Centrum Slovenskej Akademie Vied, Verejna Vyskumna Institucia, Slovakia

Centre International De Recherche Sur Le Cancer, France

Childhood Cancer International, Netherlands

Consorcio Centro de Investigacion Biomedica En Red M.P., Spain

Deutsches Krebsforschungszentrum Heidelberg, Germany

European Cancer Patient Coalition, Belgium

Fundacio Privada Institut D’investigacio Oncologica De Vallhebron (VHIO), Spain

Helsingin Yliopisto, Finland

Inserm Transfert Sa, France

Institut National de la Sante et de La Recherche Medicale, France

Institut National Du Cancer Gip, France

Instituto Portugues De Oncologia Do Porto Francisco Gentil, Epe, Portugal

Kemijski Institut, Slovenia

Luxembourg Institute Of Health, Luxembourg

Masarykuv Onkologicky Ustav, Czech Republic

Medizinische Universitaet Wien, Austria

Ministry For Health – Government Of Malta, Malta

Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie – Panstwowy Instytut Badawczy, Poland

Organisation Of European Cancer Institutes, Belgium

Orszagos Onkologiai Intezet, Hungary

Region Nordjylland (North Denmark Region), Denmark


SIOP Europe, Belgium

Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis, Netherlands

Stichting Oncode Institute, Netherlands

Tartu Ulikool, Estonia

Universite Paris-Saclay, France

University College Dublin, National University Of Ireland, Dublin, Ireland

Viesoji Istaiga Vilniaus Universiteto Ligonine Santaros Klinikos, Lithuania

Why it matters

The 15-month coordination and support action “4.UNCAN.eu” will generate a strategic agenda to launch UNCAN.eu, a European initiative to understand cancer proposed by the Mission Board and the European Beating Cancer Plan. This research agenda will be built with the final aim of achieving a new breakthrough in cancer prevention and treatment that will contribute to saving European citizens’ lives and help ensure an optimal quality of life to disease survivors.

What ECPC does

The general objectives of the project are to ensure that cancer patients and their relative have a central role and strong voice within the project activities while informing “4.UNCAN.eu” on European citizens’ expectations.

ECPC is involved in Work Package 4 that includes the role of European patients and citizens in cancer research. This Work Package comprises the following tasks and deliverables:

  • Task 4.1: Empowering cancer patients and EU citizens

D4.1 Empowering patients & citizens plan – ECPC, report PU – Public, Month 3

  • Task 4.2: Dissemination and communication strategy

D4.2 Empowering patients & citizens plan – ECPC, report PU – Public, Month 3

  • Task 4.3: Dissemination and communication activities

The specific objectives of this Work Package are:

  • To ensure that other WP leaders will properly consider patients’ unmet needs and priorities,
  • To coordinate communication within “4.UNCAN.eu” and between the consortium and external stakeholders,
  • To communicate and disseminate “4.UNCAN.eu” proposals and final outcome to the target audiences and key stakeholders (cancer patients and their relatives, care-givers, European citizens, cancer representatives and charities, healthcare professionals and academia, employers and policymakers),
  • To define the role of patients in UNCAN.eu initiative and prepare the dissemination of cancer research results among younger European citizens in order to improve cancer prevention.
EU flag logo

This project has received funding from the European Union’s Horizon Europe Coordination and Support Actions programme under grant agreement No 101069496